MOBILion Systems to Highlight Customer Use Cases from its MOBIE® Platform and Unveil Plans for their Next Generation Proteomics Platform at ASMS 2025

CHADDS FORD, Pa., May 27, 2025 /PRNewswire/ — MOBILion Systems, Inc., a leader in separation science innovation, will attend and exhibit at the 73rd Annual American Society for Mass Spectrometry (ASMS) Conference in Baltimore, MD from June 1–5. The company will highlight the transformative impact its MOBIE® High-Resolution Ion Mobility product is having across a wide range of applications and showcase early performance of its next-generation proteomics system, BILLIE™.

More than 50 abstracts including oral and poster presentations will demonstrate how independent researchers across pharmaceutical development, chiral molecule analysis, lipidomics and PFAS research are driving innovation with the MOBIE system. These real-world applications reflect growing market adoption and the expanding impact of MOBILion’s existing MOBIE product across critical and emerging workflows. Alongside its commercial platform, MOBILion will present the latest data and collaborator results powered by its most recent advancement: Parallel Accumulation Mobility Aligned Fragmentation (PAMAF). This novel mode of operation is the foundation for the forthcoming BILLIE platform, enabling increased speed, sensitivity, and selectivity for LC-HRMS-based proteomics.